A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes
Clinical trial NCT03714022 · COMPLETED
Trial details
- NCT number
- NCT03714022
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2019-04-02
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.